Ontology highlight
ABSTRACT:
SUBMITTER: Shadman M
PROVIDER: S-EPMC6849954 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
Shadman Mazyar M Gauthier Jordan J Hay Kevin A KA Voutsinas Jenna M JM Milano Filippo F Li Ang A Hirayama Alexandre V AV Sorror Mohamed L ML Cherian Sindhu S Chen Xueyan X Cassaday Ryan D RD Till Brian G BG Gopal Ajay K AK Sandmaier Brenda M BM Maloney David G DG Turtle Cameron J CJ
Blood advances 20191001 20
Allogeneic hematopoietic cell transplantation (allo-HCT) is offered to selected patients after chimeric antigen receptor-modified T-cell (CAR-T) therapy. Lymphodepleting chemotherapy and CAR-T therapy have immunosuppressive and immunomodulatory effects that could alter the safety profile of subsequent allo-HCT. We reviewed our experience with 32 adults (acute lymphoblastic leukemia [ALL], n = 19; B-cell non-Hodgkin lymphoma [NHL]/chronic lymphocytic leukemia [CLL], n = 13) who received an allo-H ...[more]